BLADDER CANCER
Clinical trials for BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new BLADDER CANCER trials appear
Sign up with your email to follow new studies for BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to shield patients from harsh chemo side effects while fighting bladder cancer
Disease control TerminatedThis study tested if adding a drug called trilaciclib to standard first-line chemotherapy and immunotherapy could better control advanced bladder cancer. The goal was to see if trilaciclib could help patients live longer without their cancer worsening while also protecting their …
Matched conditions: BLADDER CANCER
Phase: PHASE2 • Sponsor: G1 Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Terminated trial: can radiation plus immune drug fight bladder cancer?
Disease control TerminatedThis study tested whether adding an immunotherapy drug called avelumab to standard bladder radiation could help treat muscle-invasive bladder cancer. It was specifically for patients who were unable to receive the usual chemotherapy. The trial was terminated early after enrolling…
Matched conditions: BLADDER CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested a new drug called OC-001, both by itself and combined with an existing immunotherapy drug, in people with various advanced cancers that had stopped responding to standard treatments. The main goal was to check the safety of the drug and see how the b…
Matched conditions: BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Ocellaris Pharma, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Targeted drug trial for Tough-to-Treat cancers halted
Disease control TerminatedThis study tested an experimental drug called DAY101 (tovorafenib) in people aged 12 and older with advanced solid tumors that had stopped responding to other treatments. The goal was to see if the drug could shrink or control tumors that have specific genetic changes. The trial …
Matched conditions: BLADDER CANCER
Phase: PHASE2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Tracking new bladder cancer treatment in real patients
Disease control TerminatedThis study collected information about how doctors and patients used Adstiladrin treatment for bladder cancer in everyday medical practice. Researchers followed 202 patients in the US and Israel to see how well the treatment worked and what side effects occurred. The goal was to …
Matched conditions: BLADDER CANCER
Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
Could a simple urine test replace invasive biopsies for bladder cancer?
Diagnosis TerminatedThis study aimed to see if analyzing DNA from urine could match the genetic information from bladder tumor tissue samples. Researchers wanted to develop a less invasive way to guide personalized immunotherapy treatments for high-risk bladder cancer patients. The study involved 20…
Matched conditions: BLADDER CANCER
Sponsor: Hopital Foch • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
Could a simple urine test spot bladder cancer?
Diagnosis TerminatedThis study aimed to see if measuring a specific protein (DEK) in urine could help doctors diagnose bladder cancer. It involved over 1,100 adults who had symptoms like blood in their urine or painful urination. Researchers compared the urine test results to standard diagnostic pro…
Matched conditions: BLADDER CANCER
Sponsor: Medical Diagnostic Laboratories, LLC • Aim: Diagnosis
Last updated Mar 11, 2026 14:54 UTC
-
Can a phone call ease the trauma of a terminal cancer diagnosis?
Symptom relief TerminatedThis study tested a brief phone-based therapy to help patients and their partners cope with the emotional trauma of receiving news that their cancer is advanced and incurable. The therapy combined deep breathing exercises with a technique to help people structure their traumatic …
Matched conditions: BLADDER CANCER
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC